• Renewed consistent consultation growth, outpacing 2024 volumes every month since May
• Developing growth acceleration initiatives for 2026 across digital treatment, corporate weight management, and preventative health
• Sustained strong positive cashflow with £1.1m (A$2.2m) net operating and investing cash inflow in Q4 2025

Doctor Care Anywhere Group PLC (ASX:DOC) reported its Q4 2025 results, highlighting renewed consistent consultation growth, development of new growth acceleration initiatives, and sustained strong positive cashflow. Consultation volumes increased 3.4% in the second half of 2025, outpacing 2024 levels every month since May. The company is developing digital treatment pilots across MSK, Mental Health and Dermatology, which have shown encouraging early feedback, as well as new propositions in corporate weight management and preventative health assessments. Q4 2025 saw a £1.1m (A$2.2m) net operating and investing cash inflow, a material increase versus the prior year, marking the third consecutive quarter of positive cash generation. The company ended the quarter with £6.6m (A$13.2m) in cash, providing a strong capital foundation for investing in business growth. Management reiterated its medium-term targets, including revenue doubling over 3-5 years and a 15% EBITDA margin.

Management reiterates medium-term targets, including revenue doubling over 3-5 years and a 15% EBITDA margin.